Inovio Pharmaceuticals, Inc. (INO)
1.195
+0.08
(+7.66%)
USD |
NASDAQ |
Apr 15, 16:00
1.195
0.00 (0.00%)
After-Hours: 18:29
Inovio Pharmaceuticals Research and Development Expense (Annual) : 52.79M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| ADMA Biologics, Inc. | 4.762M |
| Vaxart, Inc. | 201.58M |
| Capricor Therapeutics, Inc. | 83.50M |
| Allogene Therapeutics, Inc. | 137.79M |